Dr. REX MOWAT, MD

Toledo Clinic Cancer Centers-Toledo

Expert in Cancer
Expert in Lung Cancer
77 reported clinical trials
151 drugs studied
1 year of experience

About REX MOWAT, MD

Education:

  • Earned an MD (Doctor of Medicine).

Experience:

  • Currently a practicing physician at the Toledo Clinic Cancer Center with a specialization in oncology.
  • Collaborates with the Barbara Ann Karmanos Cancer Institute to enhance access to advanced cancer care, clinical trials, and precision medicine in Northwest Ohio.

Area of expertise

1Cancer
Global Leader
REX MOWAT, MD has run 27 trials for Cancer. Some of their research focus areas include:
Stage IV
metastatic
Stage III
2Lung Cancer
Global Leader
REX MOWAT, MD has run 14 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
metastatic

Affiliated Hospitals

Image of trial facility.
Toledo Clinic Cancer Centers-Toledo
Image of trial facility.
Hickman Cancer Center

Clinical Trials REX MOWAT, MD is currently running

Image of trial facility.

GM1

for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

This phase II trial tests the safety, side effects, and best dose of monosialotetrahexosylganglioside (GM1) and whether it works in reducing or preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic) who are receiving treatment with paclitaxel. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Exposure to chemotherapy drugs like paclitaxel may cause a side effect called CIPN, which is a condition of weakness, numbness, and pain from nerve damage (usually in the hands and feet). GM1 is a part of the body's natural system that insulates nerves and helps to protect nerves from damage. Giving GM1 may help reduce or prevent CIPN in breast cancer patients receiving treatment with paclitaxel.
Recruiting0 awards Phase 222 criteria
Image of trial facility.

BRAF-Targeted Therapy

for Colon Cancer

This phase II/III trial compares treatment with encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of tumor cells. This may help keep tumor cells from growing. Giving encorafenib and cetuximab after standard surgery and chemotherapy may be more effective at reducing the chance of cancer recurrence compared to the usual patient observation.
Recruiting1 award Phase 2 & 333 criteria

More about REX MOWAT, MD

Clinical Trial Related1 year of experience running clinical trials · Led 77 trials as a Principal Investigator · 45 Active Clinical Trials
Treatments REX MOWAT, MD has experience with
  • Pembrolizumab
  • Nivolumab
  • Carboplatin
  • Fluorouracil
  • Paclitaxel
  • Biospecimen Collection

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does REX MOWAT, MD specialize in?
REX MOWAT, MD focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are metastatic.
Is REX MOWAT, MD currently recruiting for clinical trials?
Yes, REX MOWAT, MD is currently recruiting for 42 clinical trials in Toledo Ohio. If you're interested in participating, you should apply.
Are there any treatments that REX MOWAT, MD has studied deeply?
Yes, REX MOWAT, MD has studied treatments such as Pembrolizumab, Nivolumab, Carboplatin.
What is the best way to schedule an appointment with REX MOWAT, MD?
Apply for one of the trials that REX MOWAT, MD is conducting.
What is the office address of REX MOWAT, MD?
The office of REX MOWAT, MD is located at: Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio 43623 United States. This is the address for their practice at the Toledo Clinic Cancer Centers-Toledo.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.